On ECHEMI
Home > Drugs > Qingdao Huanghai Pharmaceutical Co., Ltd.
Qingdao Huanghai Pharmaceutical Co., Ltd.
  • Founded in:

    1982-02-10
  • Country:

    China China
  • Address:

    No. 17, Keyuanjingsi Road, Laoshan District, Qingdao
  • Tax NO.:

    91370200163567984Y
  • Registered Funds:

    182.18928 million yuan
  • Website:

  • Email:

Related Drugs
Metformin and Glibenclamide Tablets (Ⅰ)
This product is a compound preparation, and its components are: each tablet contains 1.25 mg of glibenclamide and 250 mg of metformin hydrochloride.
Name Description Content CAS NO. Registered Holders
Glibenclamide

Mainly stimulates pancreatic beta cells to secrete insulin to produce blood sugar lowering effect

More

Mainly stimulates pancreatic beta cells to secrete insulin to produce blood sugar lowering effect

1.25mg 10238-21-8 28
1,1-DIMETHYLBIGUANIDE HYDROCHLORIDE

It can reduce the production of glycogen in the liver, reduce intestinal absorption of sugar, and increase insulin sensitivity by increasing peripheral sugar uptake and utilization

More

It can reduce the production of glycogen in the liver, reduce intestinal absorption of sugar, and increase insulin sensitivity by increasing peripheral sugar uptake and utilization

250mg 15537-72-1 55
Theophylline sustained-release tablets
The main ingredient is theophylline, whose chemical name is 1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione-hydrate.
Name Description Content CAS NO. Registered Holders
Theophylline

It has a direct relaxant effect on the smooth muscles of the respiratory tract. Its mechanism of action includes inhibiting phosphodiesterase to increase the intracellular cAMP content, producing a bronchial dilation effect through the release of endogenous adrenaline and norepinephrine, acting as a purine receptor blocker to counteract the contractile effect of adenine on the respiratory tract, and enhancing the contractility of the diaphragm to improve respiratory function.

More

It has a direct relaxant effect on the smooth muscles of the respiratory tract. Its mechanism of action includes inhibiting phosphodiesterase to increase the intracellular cAMP content, producing a bronchial dilation effect through the release of endogenous adrenaline and norepinephrine, acting as a purine receptor blocker to counteract the contractile effect of adenine on the respiratory tract, and enhancing the contractility of the diaphragm to improve respiratory function.

58-55-9 26
Nifedipine sustained-release tablets (Ⅱ)
The main ingredient of this product is nifedipine, and its chemical name is: 2,6-dimethyl-4 (2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylic acid dimethyl ester. Its structural formula is: Molecular formula: C17H18N2O6 Molecular weight: 346.34
Name Description Content CAS NO. Registered Holders
Nifedipine

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

More

By blocking the membrane transport of calcium ions in myocardial and vascular smooth muscle, inhibiting the influx of calcium ions into cells, it causes a decrease in myocardial contractility and vasodilation. Animal experiments have shown that by reducing myocardial contractility and peripheral vascular resistance, myocardial oxygen consumption is reduced; by dilating coronary vessels and developing collateral circulation, the oxygen supply to myocardial ischemic sites is increased; by inhibiting the consumption of high-energy phosphate compounds, the ability to resist hypoxia is enhanced.

21829-25-4 74
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.